Healthsouth Corp Receives a Hold from Piper Jaffray

By Austin Angelo

In a report issued on September 13, Sarah James from Piper Jaffray reiterated a Hold rating on Healthsouth Corp (NYSE: HLS), with a price target of $50. The company’s shares closed on Friday at $44.94.

According to TipRanks.com, James is a 5-star analyst with an average return of 16.0% and a 78.2% success rate. James covers the Services sector, focusing on stocks such as WellCare Health Plans, Universal American, and Molina Healthcare.

Currently, the analyst consensus on Healthsouth Corp is Moderate Buy and the average price target is $52.25, representing a 16.3% upside.

In a report issued on September 7, KeyBanc also reiterated a Hold rating on the stock.

Based on Healthsouth Corp’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $968 million and quarterly net profit of $62.8 million. In comparison, last year the company earned revenue of $905 million and had a net profit of $62.4 million.

Based on the recent corporate insider activity of 96 insiders, corporate insider sentiment is negative on the stock. Last month, Mark Tarr, the EVP & COO of HLS sold 22,625 shares for a total of $972,875.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

HealthSouth Corp. engages in the provision of post-acute healthcare services. It operates through the Impatient Rehabilitation and Home Health and Hospice segments.